April 11, 2022
On April 11, the U.S. Department of Energy (DOE) announced $1 million in funding for isotope development. The funding will support three awards for research and development on newly developed radioisotopes for potential use in preclinical and clinical trials. The funding is part of a program to produce critical isotopes that are unavailable or in short supply for science, medicine and industry.
Topics funded seek to address key challenges associated with the advancement of therapeutic radioisotopes. Awardees include:
Total funding is $1 million for awards lasting up to two years in duration, with a total of $1 million in FY 2022 dollars and outyear funding contingent on congressional appropriations for both awards.
SNMMI is highly supportive of DOE’s funding of awards for nuclear medicine, which currently has many exciting opportunities.
Read the full announcement.